These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34934312)

  • 61. Gene-silencing effects of anti-survivin siRNA delivered by RGDV-functionalized nanodiamond carrier in the breast carcinoma cell line MCF-7.
    Bi Y; Zhang Y; Cui C; Ren L; Jiang X
    Int J Nanomedicine; 2016; 11():5771-5787. PubMed ID: 27853365
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p.
    Zhang H; Zhong J; Bian Z; Fang X; Peng Y; Hu Y
    Biomed Pharmacother; 2017 Mar; 87():683-691. PubMed ID: 28088735
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Impact of the biological function on epithelial ovarian cancer with ITIH4 gene expression down-regulating in vitro].
    Huang M; Wang Q; Zhang W; Li DR; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jan; 48(1):34-40. PubMed ID: 23531249
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Modulated cellular delivery of anti-VEGF siRNA (bevasiranib) by incorporating supramolecular assemblies of hydrophobically modified polyamidoamine dendrimer in stealth liposomes.
    Golkar N; Samani SM; Tamaddon AM
    Int J Pharm; 2016 Aug; 510(1):30-41. PubMed ID: 27291973
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Inhibitory effect of silencing STAT3 gene with short hairpin RNA mediated by polyamidoamine dendrimers on growth of prostate cancer].
    Zhao WM; Xiu YC; Xu Y; Wang YM; Cheng ZK; Yu Q; Kong DL
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):575-9. PubMed ID: 18210874
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Expression of Bmi-1 gene in esophageal carcinoma cell EC9706 and its effect on cell cycle, apoptosis and migration.
    Wang JF; Liu Y; Liu WJ; He SY
    Chin J Cancer; 2010 Jul; 29(7):689-96. PubMed ID: 20591222
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
    Gu WJ; Liu HL
    Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.
    Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z
    Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Transfer of siRNA against XIAP induces apoptosis and reduces tumor cells growth potential in human breast cancer in vitro and in vivo.
    Zhang Y; Wang Y; Gao W; Zhang R; Han X; Jia M; Guan W
    Breast Cancer Res Treat; 2006 Apr; 96(3):267-77. PubMed ID: 16341821
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Co-delivery of gambogenic acid and VEGF-siRNA with anionic liposome and polyethylenimine complexes to HepG2 cells.
    Yu Q; Zhang B; Zhou Y; Ge Q; Chang J; Chen Y; Zhang K; Peng D; Chen W
    J Liposome Res; 2019 Dec; 29(4):322-331. PubMed ID: 29745740
    [No Abstract]   [Full Text] [Related]  

  • 71. RNAi knockdown of PIK3CA preferentially inhibits invasion of mutant PIK3CA cells.
    Zhou XK; Tang SS; Yi G; Hou M; Chen JH; Yang B; Liu JF; He ZM
    World J Gastroenterol; 2011 Aug; 17(32):3700-8. PubMed ID: 21990951
    [TBL] [Abstract][Full Text] [Related]  

  • 72. N-Isopropylacrylamide-modified polyethylenimine-mediated p53 gene delivery to prevent the proliferation of cancer cells.
    Zhang J; Wu D; Xing Z; Liang S; Han H; Shi H; Zhang Y; Yang Y; Li Q
    Colloids Surf B Biointerfaces; 2015 May; 129():54-62. PubMed ID: 25829127
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Growth inhibition of breast cancer cells in vitro and in vivo by siRNA targeting signal transducers and activators of transcription 3].
    Yang Z; Yan L; Zhang F; Yan QH; Song WQ; Wang FA; Cai JH
    Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):819-24. PubMed ID: 21223686
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmaceutically inhibiting polo-like kinase 1 exerts a broad anti-tumour activity in retinoblastoma cell lines.
    Schwermer M; Dreesmann S; Eggert A; Althoff K; Steenpass L; Schramm A; Schulte JH; Temming P
    Clin Exp Ophthalmol; 2017 Apr; 45(3):288-296. PubMed ID: 27647547
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ultrasonic irradiation and SonoVue microbubbles-mediated RNA interference targeting PRR11 inhibits breast cancer cells proliferation and metastasis, but promotes apoptosis.
    Luo H; Li J; Lin Q; Xiao X; Shi Y; Ye X; Wei Z; Liu Y; Xu J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33057583
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of lentiviral-mediated Foxp1 and Foxq1 RNAi on the hepatocarcinoma cell.
    Qin J; Xu Y; Li X; Wu Y; Zhou J; Wang G; Chen L
    Exp Mol Pathol; 2014 Feb; 96(1):1-8. PubMed ID: 24211718
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of CD133 Silencing on Survival and Migration of HT-29 Colorectal Cancer Cells.
    Akbari M; Shanehbandi D; Asadi M; Shomali N; Faraji A; Khaze V; Pakdel A; Mokhtarzadeh A; Ebrahimi AA; Shabani A; Bardaran B
    Iran J Immunol; 2019 Sep; 16(3):246-257. PubMed ID: 31552833
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma.
    Mok WC; Wasser S; Tan T; Lim SG
    World J Gastroenterol; 2012 Jul; 18(27):3527-36. PubMed ID: 22826617
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Effects of specific siRNA targeting at bcr-abl fusion gene and its combination with p27 gene clone on chronic myeloid leukemia cell line K562].
    Wang W; DU Y; Lin GQ; Li NN; Sun BZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):606-11. PubMed ID: 20561411
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells.
    Zhang C; Yuan W; Wu Y; Wan X; Gong Y
    Life Sci; 2021 Feb; 266():118886. PubMed ID: 33310044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.